Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001346824-25-000063·Evommune, Inc.
Schedule 13D ownership disclosure
Evommune Inc
Common Stock, $0.0001 par value per share · CUSIP: 30054Y107
Event date: 2025-11-07
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.Reported CIK 0001346824
Shares: 3,458,770.00 · Class: 11.0%
- Peter KolchinskyReported CIK 0001384859
Shares: 3,458,770.00 · Class: 11.0%
- Rajeev ShahReported CIK 0001619841
Shares: 3,458,770.00 · Class: 11.0%
- RA Capital Healthcare Fund, L.P.Reported CIK 0001315082
Shares: 2,674,425.00 · Class: 8.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001346824-25-000063
- Form type
- SCHEDULE 13D
- Filer
- Evommune, Inc.
- CIK
- CIK 2044725
- Filed
- Nov 17, 2025
- Reporting period
- Nov 07, 2025
- Description
- Schedule 13D beneficial ownership